Linsitinib
- Generic Name
- Linsitinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H23N5O
- CAS Number
- 867160-71-2
- Unique Ingredient Identifier
- 15A52GPT8T
- Background
An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. IGF-1R inhibitor OSI-906 selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis.
- Indication
Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath